(Q79916220)
Statements
The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy (English)
Sven Saussez
Francois Lorfevre
Thomas Lequeux
Guy Laurent
Gilbert Chantrain
Francoise Vertongen
Gérard Toubeau
Christine Decaestecker
9 March 2007